These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6933531

  • 1. Cycle-related toxicity and transformation in 10T1/2 cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Grisham JW, Greenberg DS, Kaufman DG, Smith GJ.
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4813-7. PubMed ID: 6933531
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity of monofunctional alkylating agents. Methyl methanesulfonate and methyl-N'-nitro-N-nitrosoguanidine have different mechanisms of toxicity for 10T1/2 cells.
    Smith GJ, Grisham JW.
    Mutat Res; 1983 Nov; 111(3):405-17. PubMed ID: 6646150
    [Abstract] [Full Text] [Related]

  • 3. Differential cell cycle phase specificity for neoplastic transformation and mutation to ouabain resistance induced by N-methyl-N'-nitro-N-nitrosoguanidine in synchronized C3H10T 1/2 C18 cells.
    McCormick PJ, Bertram JS.
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4342-6. PubMed ID: 6956864
    [Abstract] [Full Text] [Related]

  • 4. Induction of foci of morphologically transformed cells in synchronized populations of 10T1/2 cells by N-methyl-N'-nitro-N-nitrosoguanidine and the effect of spontaneous transformation on calculated transformation frequency.
    Grisham JW, Smith GJ, Lee LW, Bentley KS, Fatteh MV.
    Cancer Res; 1988 Nov 01; 48(21):5977-83. PubMed ID: 2844394
    [Abstract] [Full Text] [Related]

  • 5. Cycle-dependent removal of certain methylated bases from DNA of 10T1/2 cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Smith GJ, Grisham JW, Kaufman DG.
    Cancer Res; 1981 Apr 01; 41(4):1373-8. PubMed ID: 7214324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initiation of C3H/10T1/2 cell transformation by N-methyl-N'-nitro-N-nitrosoguanidine and aflatoxin B1.
    Boreiko CJ, Ragan DL, Abernethy DJ, Frazelle JH.
    Carcinogenesis; 1982 Apr 01; 3(4):391-5. PubMed ID: 6807561
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of morphological transformation induced with N-methyl-N'-nitro-N-nitrosoguanidine in cultures of hamster embryo cells by 5'-bromo-2'-deoxyuridine-photolysis.
    Mironescu SG.
    Int J Cancer; 1978 Sep 15; 22(3):304-14. PubMed ID: 700893
    [Abstract] [Full Text] [Related]

  • 10. Chemical oncogenesis in cultured mouse embryo cells in relation to the cell cycle.
    Bertram JS, Peterson AR, Heidelberger C.
    In Vitro; 1975 Sep 15; 11(2):97-106. PubMed ID: 1171081
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of direct correlation among repair, oncogenesis, and lethality in cultured synchronized mouse fibroblasts treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Bertram JS, Peterson AR, Heidelberger C.
    Basic Life Sci; 1975 Sep 15; 5B():789-92. PubMed ID: 1191199
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle perturbation and cell death after exposure of a human lymphoblastoid cell strain to N-methyl-N'-nitro-N-nitrosoguanidine.
    Black KA, McFarland RD, Grisham JW, Smith GJ.
    Am J Pathol; 1989 Jan 15; 134(1):53-61. PubMed ID: 2913827
    [Abstract] [Full Text] [Related]

  • 14. Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line.
    Bignami M, Ficorella C, Dogliotti E, Norman RL, Kaighn ME, Saffiotti U.
    Cancer Res; 1984 Jun 15; 44(6):2452-7. PubMed ID: 6722787
    [Abstract] [Full Text] [Related]

  • 15. Morphological transformation of C3H/10T1/2 CL8 cells by alkylating agents.
    Oshiro Y, Balwierz PS, Molinary SV.
    Toxicol Lett; 1981 Dec 15; 9(4):301-6. PubMed ID: 7330894
    [Abstract] [Full Text] [Related]

  • 16. Mutagenicity and mutational spectrum of N-methyl-N'-nitro-N-nitrosoguanidine in the hprt gene in G1-S and late S phase of diploid human fibroblasts.
    Yang JL, Lin JG, Hu MC, Wu CW.
    Cancer Res; 1993 Jun 15; 53(12):2865-73. PubMed ID: 8504428
    [Abstract] [Full Text] [Related]

  • 17. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N'-nitro-N-nitrosoguanidine.
    Scudiero DA, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CH, Day RS.
    Cancer Res; 1984 Mar 15; 44(3):961-6. PubMed ID: 6692418
    [Abstract] [Full Text] [Related]

  • 18. Antipain inhibits N-methyl-N'-nitro-N-nitrosoguanidine-induced transformation and increases chromosomal aberrations.
    DiPaolo JA, Amsbaugh SC, Popescu NC.
    Proc Natl Acad Sci U S A; 1980 Nov 15; 77(11):6649-53. PubMed ID: 6935676
    [Abstract] [Full Text] [Related]

  • 19. Split-dose exposure to N-methyl-N'-nitro-N-nitrosoguanidine in BALB/3T3 C1 a31-1-1 cells: evidence of DNA repair by alkaline elution without changes in cell survival, mutation and transformation rates.
    Bignami M, Dogliotti E, Benigni R, Kaighn ME, Saffiotti U.
    Mutat Res; 1985 Nov 15; 145(1-2):81-8. PubMed ID: 3974606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.